Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry

被引:45
|
作者
Work, M. E. [1 ]
John, E. M. [2 ,3 ,4 ]
Andrulis, I. L. [5 ]
Knight, J. A. [5 ,6 ]
Liao, Y. [1 ]
Mulligan, A. M. [7 ,8 ]
Southey, M. C. [9 ]
Giles, G. G. [10 ,11 ]
Dite, G. S. [11 ]
Apicella, C. [11 ]
Hibshoosh, H. [12 ,13 ]
Hopper, J. L. [11 ,12 ,13 ]
Terry, M. B. [1 ,14 ]
机构
[1] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA
[2] Canc Prevent Inst Calif, Fremont, CA 94538 USA
[3] Stanford Univ, Div Epidemiol, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA
[4] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA
[5] Univ Toronto, Samuel Lunenfeld Res Inst, Mt Sinai Hosp, Dept Mol Genet, Toronto, ON M5G 1X5, Canada
[6] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5T 3M7, Canada
[7] Univ Hlth Network, Lab Med Program, Toronto, ON M5G 1X5, Canada
[8] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
[9] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[10] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia
[11] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia
[12] Seoul Natl Univ, Dept Epidemiol, Sch Publ Hlth, Seoul 110799, South Korea
[13] Seoul Natl Univ, Inst Hlth & Environm, Sch Publ Hlth, Seoul 110799, South Korea
[14] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
breast cancer; epidemiology; breastfeeding; oral contraceptives; ORAL-CONTRACEPTIVE USE; MENOPAUSAL HORMONE-THERAPY; JOINT ESTROGEN-RECEPTOR; PROGESTERONE; SUBTYPES; WOMEN; ASSOCIATION; AGE; CARRIERS; HISTORY;
D O I
10.1038/bjc.2013.807
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Oestrogen receptor (ER)- and progesterone receptor (PR)-negative (ER-PR-) breast cancer is associated with poorer prognosis compared with other breast cancer subtypes. High parity has been associated with an increased risk of ER-PR- cancer, but emerging evidence suggests that breastfeeding may reduce this risk. Whether this potential breastfeeding benefit extends to women at high risk of breast cancer remains critical to understand for prevention. Methods: Using population-based ascertained cases (n = 4011) and controls (2997) from the Breast Cancer Family Registry, we examined reproductive risk factors in relation to ER and PR status. Results: High parity (>= 3 live births) without breastfeeding was positively associated only with ER-PR- tumours (odds ratio (OR) = 1.57, 95% confidence interval (CI), 1.10-2.24); there was no association with parity in women who breastfed (OR = 0.93, 95% CI 0.71-1.22). Across all race/ethnicities, associations for ER-PR- cancer were higher among women who did not breastfeed than among women who did. Oral contraceptive (OC) use before 1975 was associated with an increased risk of ER-PR- cancer only (OR = 1.32, 95% CI 1.04-1.67). For women who began OC use in 1975 or later there was no increased risk. Conclusions: Our findings support that there are modifiable factors for ER-PR- breast cancer and that breastfeeding in particular may mitigate the increased risk of ER-PR- cancers seen from multiparity.
引用
收藏
页码:1367 / 1377
页数:11
相关论文
共 50 条
  • [1] Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
    M E Work
    E M John
    I L Andrulis
    J A Knight
    Y Liao
    A M Mulligan
    M C Southey
    G G Giles
    G S Dite
    C Apicella
    H Hibshoosh
    J L Hopper
    M B Terry
    [J]. British Journal of Cancer, 2014, 110 : 1367 - 1377
  • [2] Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
    McCredie, MRE
    Dite, GS
    Southey, MC
    Venter, DJ
    Giles, GG
    Hopper, JL
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (09) : 1661 - 1663
  • [3] Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
    M R E McCredie
    G S Dite
    M C Southey
    D J Venter
    G G Giles
    J L Hopper
    [J]. British Journal of Cancer, 2003, 89 : 1661 - 1663
  • [4] Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors
    Rauscher, Garth H.
    Campbell, Richard T.
    Wiley, Elizabeth L.
    Hoskins, Kent
    Stolley, Melinda R.
    Warnecke, Richard B.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2016, 183 (10) : 884 - 893
  • [5] Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    [J]. HUMAN PATHOLOGY, 2015, 46 (11) : 1776 - 1784
  • [6] Differences in estrogen receptor-negative breast cancer by race and SEER registry
    Lynn, Brittny C. Davis
    Chernyavskiy, Pavel
    Anderson, William F.
    Gierach, Gretchen L.
    Rosenberg, Philip S.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [7] Hormone receptor-negative breast cancer: a study of prognostic factors
    Soares, R.
    Shvets, Y.
    Faustino, I.
    Afonso, N.
    Sousa, S.
    Rodrigues, H.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 106 - 106
  • [8] Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer
    Pivot, Xavier B.
    Li, Rubi K.
    Thomas, Eva S.
    Chung, Hyun-Cheol
    Fein, Luis E.
    Chan, Valorie F.
    Jassem, Jacek
    de Mendoza, Fernando Hurtado
    Mukhopadyay, Pralay
    Roche, Henri H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (17) : 2940 - 2946
  • [9] Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer
    Nikoic-Vukosavljevic, D
    Kanjer, K
    Neskovic-Konstantinovic, Z
    Vukotic, D
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 196 - 200
  • [10] Estrogen Receptor Positive and Progesterone Receptor-negative Breast Cancer: The Role of Hormone Therapy
    Habibi, Mehran
    Canner, Joseph
    Dembinski, Robert
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S467 - S467